Therapeutic psychedelics according to Johns Hopkins

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew JohnsonПодробнее

Psychedelics can provide long term behavioral impact - Johns Hopkins MedicineПодробнее

A Johns Hopkins Neuroscientist on Psychedelics and Mental HealthПодробнее

Johns Hopkins Psychiatry Rounds | Psilocybin Research for Substance Use DisordersПодробнее

The Johns Hopkins Congressional Briefing: What’s Next for PsychedelicsПодробнее

Diet Therapy for Adults and Children with EpilepsyПодробнее

The Johns Hopkins Briefing: Prescription Drug ShortagesПодробнее

Johns Hopkins Psychiatry Grand Rounds | Psychedelic Treatment LandscapeПодробнее

Myositis Research Webinar with Dr. Julie Paik, MD, MHS-Johns Hopkins University School of Medicine.Подробнее

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew JohnsonПодробнее

Johns Hopkins Psychiatry Grand Rounds – Neuropsychopharmacology of Psychedelic DrugsПодробнее

Psychedelic Assisted Therapy - Immersive Sound Experience - 001Подробнее

An Evening With Hamilton Morris, hosted by the Johns Hopkins Psychedelic SocietyПодробнее

COVID-19 Update with Dr. Auwaerter of Johns Hopkins : Omicron Variant, Testing, and TreatmentПодробнее

Psychedelic-Assisted Therapy with a Johns Hopkins ResearcherПодробнее

Johns Hopkins Medicine Receives First Federal Grant For Psychedelic Treatment Research In 50 yearsПодробнее

Treatment Options for Rheumatoid Arthritis | Johns Hopkins RheumatologyПодробнее

Psychedelic Spotlight Interview With Johns Hopkins, Dr. Albert Garcia-RomeuПодробнее

PsyTech Summit: An Overview of Johns Hopkins Psychedelic Research Matthew W Johnson, Ph D with Q&AПодробнее